Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy

Abstract The fatty acid-binding protein4 (FABP4) and vascular endothelial growth factor A (VEGFA) play key roles in the metabolic and cardiovascular diseases, and proliferative diabetic retinopathy (PDR), respectively. To identify FABP4 in vitreous fluid in PDR, vitreous concentrations of FABP4 (V-F...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaku Itoh, Masato Furuhashi, Yosuke Ida, Hiroshi Ohguro, Megumi Watanabe, Soma Suzuki, Fumihito Hikage
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/26feea154246441f8f7b8d7fe773d6fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26feea154246441f8f7b8d7fe773d6fd
record_format dspace
spelling oai:doaj.org-article:26feea154246441f8f7b8d7fe773d6fd2021-12-02T15:03:07ZDetection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy10.1038/s41598-021-91857-12045-2322https://doaj.org/article/26feea154246441f8f7b8d7fe773d6fd2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91857-1https://doaj.org/toc/2045-2322Abstract The fatty acid-binding protein4 (FABP4) and vascular endothelial growth factor A (VEGFA) play key roles in the metabolic and cardiovascular diseases, and proliferative diabetic retinopathy (PDR), respectively. To identify FABP4 in vitreous fluid in PDR, vitreous concentrations of FABP4 (V-FABP4) and VEGFA (V-VEGFA) from PDR (n = 20) and non-PDR (n = 20) patients were determined by Enzyme-Linked ImmunoSorbent Assays. The data, which included height and weight, systemic blood pressures, several blood biochemical parameters and blood flow at the optic nerve head (ONH) by laser speckle flowgraphy (LSFG) were collected. The levels of V-FABP4 and V-VEGFA were significantly higher in PDR patients than in non-PDR patients (P < 0.001) with a high positive correlation (r = 0.72, P < 0.001) between them. The findings were not affected by body mass index values and the presence of vitreous hemorrhaging. Among the clinical parameters, V-FABP4 correlated positively with creatinine and negatively with age and aspartate transaminase (AST) levels, while V-VEGFA correlated positively with fasting plasma glucose and hemoglobin A1c (HbA1c) levels but negatively with AST. Multiple regression analyses indicated that V-VEGFA, or V-FABP4, AST and HbA1c were independent predictors of V-FABP4 or V-VEGFA, respectively. Both were negatively correlated, but more evident in V-FABP4, with the ONH ocular blood flow.Kaku ItohMasato FuruhashiYosuke IdaHiroshi OhguroMegumi WatanabeSoma SuzukiFumihito HikageNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kaku Itoh
Masato Furuhashi
Yosuke Ida
Hiroshi Ohguro
Megumi Watanabe
Soma Suzuki
Fumihito Hikage
Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
description Abstract The fatty acid-binding protein4 (FABP4) and vascular endothelial growth factor A (VEGFA) play key roles in the metabolic and cardiovascular diseases, and proliferative diabetic retinopathy (PDR), respectively. To identify FABP4 in vitreous fluid in PDR, vitreous concentrations of FABP4 (V-FABP4) and VEGFA (V-VEGFA) from PDR (n = 20) and non-PDR (n = 20) patients were determined by Enzyme-Linked ImmunoSorbent Assays. The data, which included height and weight, systemic blood pressures, several blood biochemical parameters and blood flow at the optic nerve head (ONH) by laser speckle flowgraphy (LSFG) were collected. The levels of V-FABP4 and V-VEGFA were significantly higher in PDR patients than in non-PDR patients (P < 0.001) with a high positive correlation (r = 0.72, P < 0.001) between them. The findings were not affected by body mass index values and the presence of vitreous hemorrhaging. Among the clinical parameters, V-FABP4 correlated positively with creatinine and negatively with age and aspartate transaminase (AST) levels, while V-VEGFA correlated positively with fasting plasma glucose and hemoglobin A1c (HbA1c) levels but negatively with AST. Multiple regression analyses indicated that V-VEGFA, or V-FABP4, AST and HbA1c were independent predictors of V-FABP4 or V-VEGFA, respectively. Both were negatively correlated, but more evident in V-FABP4, with the ONH ocular blood flow.
format article
author Kaku Itoh
Masato Furuhashi
Yosuke Ida
Hiroshi Ohguro
Megumi Watanabe
Soma Suzuki
Fumihito Hikage
author_facet Kaku Itoh
Masato Furuhashi
Yosuke Ida
Hiroshi Ohguro
Megumi Watanabe
Soma Suzuki
Fumihito Hikage
author_sort Kaku Itoh
title Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
title_short Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
title_full Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
title_fullStr Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
title_full_unstemmed Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
title_sort detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/26feea154246441f8f7b8d7fe773d6fd
work_keys_str_mv AT kakuitoh detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT masatofuruhashi detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT yosukeida detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT hiroshiohguro detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT megumiwatanabe detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT somasuzuki detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
AT fumihitohikage detectionofsignificantlyhighvitreousconcentrationsoffattyacidbindingprotein4inpatientswithproliferativediabeticretinopathy
_version_ 1718389066180853760